Tobira Therapeutics, Inc. Debt Conversion, Converted Instrument, Amount
Tobira Therapeutics, Inc. reported Debt Conversion, Converted Instrument, Amount of $48.22 million for the 12-month period ending 2015-12-31, per its 10-K filed 2016-03-03.
Discontinued › Cash Flow › Financing Activities
us-gaap:DebtConversionConvertedInstrumentAmount1 · last filed 2016-08-09
- Tobira Therapeutics, Inc. debt conversion, converted instrument, amount for the quarter ending 2015-12-31 was $1.00K.
- Tobira Therapeutics, Inc. debt conversion, converted instrument, amount for the quarter ending 2015-09-30 was -$1.00K.
- Tobira Therapeutics, Inc. debt conversion, converted instrument, amount for fiscal 2015 was $48.22M.
- Tobira Therapeutics, Inc. debt conversion, converted instrument, amount for fiscal 2012 was $7.12M.
| Period end | Debt Conversion, Converted Instrument, Amount 3 month | Debt Conversion, Converted Instrument, Amount 6 month | Debt Conversion, Converted Instrument, Amount 6 month as first filed | Debt Conversion, Converted Instrument, Amount 9 month | Debt Conversion, Converted Instrument, Amount 12 month | Debt Conversion, Converted Instrument, Amount 142 month | Debt Conversion, Converted Instrument, Amount 145 month | Debt Conversion, Converted Instrument, Amount 148 month |
|---|---|---|---|---|---|---|---|---|
| 2015-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-03 | $0.00 derived: sum of 2 quarters · filed 2016-03-03 | $48.22M 10-K · filed 2016-03-03 | |||||
| 2015-09-30 | -$1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-10 | $48.22M 10-Q · filed 2015-11-10 | ||||||
| 2015-06-30 | $48.22M 10-Q · filed 2016-08-09 | $48.22M 10-Q · filed 2015-08-11 | ||||||
| 2014-03-31 | $15.15M 10-Q · filed 2014-05-13 | |||||||
| 2013-12-31 | $15.42M 10-K · filed 2014-03-12 | |||||||
| 2013-09-30 | $15.15M 10-Q · filed 2013-11-08 | |||||||
| 2012-12-31 | $7.12M 10-K · filed 2014-03-12 |